Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Laser light may speed up recovery for elite soldiers

NCT ID NCT06380179

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether shining a low-level laser on the thighs after exercise helps Special Forces soldiers recover faster and perform better. Twenty-nine soldiers received either real or fake laser treatment three times a week for three weeks. Researchers measured their jump performance, muscle strength, pain, fatigue, and sleep using special devices and questionnaires. The goal was to see if this simple, noninvasive therapy could become a regular part of military training.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Low-level laser therapy (photobiomodulation) applied to the thigh muscles
What this could lead to
If it works, this could point toward a simple, noninvasive way to help athletes and soldiers recover faster after intense training.
What could go wrong
This is a small, early study in a very specific group (Special Forces soldiers), so results may not apply to the general public. The treatment is only for recovery, not for treating any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

29 people

The number who actually took part.

Started

Jan 2025

Finished

Mar 2026

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Active-Duty Special Forces Personnel (18-series) * Able to read and understand English language for consent purposes * Able to commit to study intervention and follow-up * Able to participate in THOR3 coach-lead training, without restriction Exclusion Criteria: * Obese (body fat \> 25%) * Cardiovascular disease * Use of select medications (e.g., statins, diuretics, hypertensive agents) * Female * Tattoo in treatment area (body region) * Diagnosis with porphyria (light induced allergy) or photosensitive eczema * Current use of medications associated with sensitivity to heat or light (e.g., amiodarone, chlorpromazine, doxycycline, hydrochlorothiazide, nalidixic acid, naproxen, piroxicam, tetracycline, thioridazine, voriconazole) * Use of pacemaker/underlying cardiac disease * Diagnosed with autoimmune disease(s) * Albinism * Peripheral Neuropathy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low level laser therapy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Joint Base Lewis-McChord

    Joint Base Lewis McChord, Washington, 98433, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.